Lista de obras -

A Bbeta 14 Arg --> Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III)

scientific article published on 26 September 2006

Absorption and efficacy of acetylsalicylic acid in patients with short bowel syndrome.

artículo científico publicado en 2014

Anticoagulant activity of dextran derivatives ⬇️

artículo científico publicado el 1 de julio de 1998

Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists ⬇️

artículo científico publicado el 22 de marzo de 2013

Assessment of primary haemostasis with a new recombinant von Willebrand factor in patients with von Willebrand disease

scientific article published on 22 December 2019

Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.

artículo científico publicado en 2015

Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause ⬇️

artículo científico publicado el 4 de agosto de 2010

Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction

scientific article published on 01 January 1998

Diagnostic value of two rapid and individual D-dimer assays in patients with clinically suspected pulmonary embolism: comparison with microplate enzyme-linked immunosorbent assay

artículo científico publicado en 1998

Evolution of circulating procoagulant microparticles during normal pregnancy

artículo científico publicado en 2008

Factor XI deficiency: identification of six novel missense mutations (P23L, P69T, C92G, E243D, W497C and E547K)

scientific article published on 01 August 2005

Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study

artículo científico publicado en 2015

Fibrinogen Saint-Germain I: a case of the heterozygous Aalpha GLY 12 --> VAL fibrinogen variant

artículo científico publicado en 2002

Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation

scientific article published on 01 November 2005

Four novel FXI gene mutations in three factor XI- deficient patients

scientific article published on 01 April 2008

High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors

artículo científico publicado en 2003

Iloprost Use in Patients with Persistent Intestinal Ischemia Unsuitable for Revascularization

artículo científico publicado en 2017

Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.

artículo científico publicado en 1998

OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?

artículo científico publicado en 2016

Pregnancy and vascular liver disease

artículo científico publicado en 2015

Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events.

artículo científico

Real-world use of idarucizumab for dabigatran reversal in three cases of serious bleeding.

artículo científico publicado en 2017

Recurrent thromboembolism in a patient with beta-thalassemia major associated with double heterozygosity for factor V R506Q and prothrombin G20210A mutations

artículo científico publicado en 2002

Response to Wiewel-Verschueren S et al.: gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.

artículo científico publicado en 2016

Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study

artículo científico publicado en 2017

Thrombin generation in patients with non-cirrhotic vascular liver diseases treated or not treated with vitamin K antagonist

artículo científico publicado en 2017

Thrombin generation in two FXI-deficient patients treated with Hemoleven®.

artículo científico publicado en 2014

Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis

artículo científico publicado en 2013

Lista de obras de

A Bbeta 14 Arg --> Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III)

Absorption and efficacy of acetylsalicylic acid in patients with short bowel syndrome.

Anticoagulant activity of dextran derivatives ⬇️

Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists ⬇️

Assessment of primary haemostasis with a new recombinant von Willebrand factor in patients with von Willebrand disease

Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.

Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause ⬇️

Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction

Diagnostic value of two rapid and individual D-dimer assays in patients with clinically suspected pulmonary embolism: comparison with microplate enzyme-linked immunosorbent assay

Evolution of circulating procoagulant microparticles during normal pregnancy

Factor XI deficiency: identification of six novel missense mutations (P23L, P69T, C92G, E243D, W497C and E547K)

Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study

Fibrinogen Saint-Germain I: a case of the heterozygous Aalpha GLY 12 --> VAL fibrinogen variant

Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation

Four novel FXI gene mutations in three factor XI- deficient patients

High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors

Iloprost Use in Patients with Persistent Intestinal Ischemia Unsuitable for Revascularization

Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.

OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?

Pregnancy and vascular liver disease

Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events.

Real-world use of idarucizumab for dabigatran reversal in three cases of serious bleeding.

Recurrent thromboembolism in a patient with beta-thalassemia major associated with double heterozygosity for factor V R506Q and prothrombin G20210A mutations

Response to Wiewel-Verschueren S et al.: gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.

Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study

Thrombin generation in patients with non-cirrhotic vascular liver diseases treated or not treated with vitamin K antagonist

Thrombin generation in two FXI-deficient patients treated with Hemoleven®.

Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis